I-Chang Hsieh ,M.D.
Intitution: Linkou Chang Gung Memorial Hospital / Chang Gung University
Position: Associate professor / Director of PCI Center of Chang Gung Memorial Hospital 
Department: Cardiology Dept.
Mail Address: No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.)
Tel: +886-3-3281200 ext.8117 Fax: +886-3-3289134
E-mail: yc82825@gmail.com
Focus of Interest:- Cardiac Catheterization (Diagnostic and Interventional)
- Coronary Interventions
- Carotid and PeripheralVascular Interventions
- Congenital Heart Disease Intervention (ASD septal occluder)
- Percutaneous valvuloplasty
- Cardiac Electrophysiology
- Echocardiography
Employment Records: 1995/01/01~1997/12/31 Chart Committee, CGMH
1997/01/01~2000/12/31 Critical Care Committee, CGMH
2001/01/01~2002/12/31 Transfusion Committee, CGMH
2003/01/01~2003/12/31 Emergency Committee, CGMH
2004/01/01~2005/12/31 Pharmaceutical Committee, CGMH
2006/01/01~2007/01/01 Radiation Protection Committee, CGMH
2006/01/01~2008/12/31 Chart Committee, CGMH
2006/12/10~2009/12/10 Board member of Taiwan Society of Cardiovascular Intervension
2009/12/10~2011/12/10 Board member of TSCI
2009/10/01~2012/09/30 Executive Director of The Society of Lipid and Atherosclerosis in Republic of China
2010/06/01~2010/05/30 Director of Interventional Committee of Taiwan Society of Cardiology(TSOC)
2010/01/01~2011/12/31 Pharmaceutical Committee, CGMH
2011/12/10~present Board member of TSCI
2012/10/01~present Board member of The Society of Lipid and Atherosclerosis in Republic of China
Education: 1981/10/01~1987/05/30 Medical Student Kaohsiung Medical College
Kaohsiung, Taiwan
1987/06/01~1988/05/30 Internship National Taiwan University Hospital
Taipei, Taiwan
Selected Publications:
- Hsieh IC, Chang HJ, Chern MS, Hung KC, Lin FC, Wu D*. Late coronary artery stenting in patients with acute myocardial infarction. Am Heart J. 1998; 136:606-12. (SCI)
- Hsieh IC, Chern MS, Chang HJ, Hung KC, Lin FC, Wu D*. Clinical and angiographic outcomes are similar with half, single or multiple contiguous Palmaz-Schatz stent implantations for a single coronary narrowing. Am J Cardiol. 1999;84:970-975. (SCI)
- Hsieh MJ, Chen CC, Chang SH, Wang CY, Lee CH, Lin FC, Chang CJ, Hsieh IC*. Long-term outcomes of drug-eluting stents versus bare-metal stents in large coronary arteries. Int J Cardiol. 2013 Oct 9;168(4):3785-90. 2013 Jul 2. [Epub ahead of print] (SCI)
- Hsieh IC*, Chen CC, Chang SH, Hsieh MJ, Wang CY, Lee CH, Lin FC. Acute and long-term outcomes of drug-eluting stent implantations in aorto-ostial, left anterior descending artery-ostial and non-ostial lesions. Catheterization and Cardiovascular Interventions. 2013 Nov 1;82(5):727-34. Epub 2013 May 15. (SCI)
- Hsieh IC, Hsieh MJ, Chang SH, Wang CY, Lee CH, Lin FC, Chen CC. Clinical and angiographic outcomes after intracoronary bare-metal stenting. PLos ONE. (in press)
Full Publication List
Ongoing Projects:
1. EXenatide Study of Cardiovascular Event Lowering Trial (EXSCEL) A Randomized， Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus.
2. A randomized， double-blind， placebo-controlled， event-driven trial of quarterly subcutaneous canakinumab in the prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with elevated hsCRP
3. Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at a High-Risk for Vascular Outcomes - the ACCELERATE Study
4. A Double-blind，Randomized，Placebo-controlled，Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination With Statin Therapy In Patients with Clinically Evident Cardiovascular Disease
5. A randomized， double-blind trial to compare the efficacy of otamixaban with Unfractionated Heparin+eptifibatide， in patients with Unstable angina/Not ST segment Elevation Myocardial infarction scheduled to undergo an early invasive strategy.
6. TECOS : A Randomized， Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Mono- or Dual Combination Oral Antihyperglycemic Therapy
7. Effects of ivabradine on plaque burden， morphology and composition in patients with clinically indicated coronary angiography. A randomised double-blind placebo-controlled international multicentre study. (MODIFY)
8. Observational Study of Dual Antiplatelet Therapy in Taiwanese Patients with Acute Coronary Syndromes Undergoing Stent Placement